Clinical Analysis of Neonatal Hyperbilirubinemia Caused by Glucose-6-Phosphate Dehydrogenase Deficiency Combine with ABO Blood Group Incompatibility Hemolysis

Li Yang,Yu Gao,Bin Xia,Xueqin Han,Jie Gao
DOI: https://doi.org/10.3877/cma.j.issn.1673-5250.2014.03.007
2014-01-01
Abstract:Objective\r\nTo investigate the clinical manifestations and laboratory examination results of the neonatal hyperbilirubinemia caused by glucose-6-phosphate dehydrogenase (G-6-PD) deficiency combine with ABO blood group incompatibility hemolysis to the G-6-PD deficiency or the ABO blood group incompatibility hemolysis.\r\n\r\n\r\nMethods\r\nA total of 643 cases of full-term newborn infant which were treated and diagnosed as neonatal G-6-PD deficiency and ABO blood group incompatibility hemolysis hospitalized in West China Second University Hospital, Sichuan University from January 2008 to December 2012 were chosen as study subjects.According to the types of diseases, they were divided into 3 groups: group A (n=20, G-6-PD deficiency combine with ABO blood group incompatibility hemolysis group), group B (n=52, G-6-PD deficiency group), group C (n=571, ABO blood group incompatibility hemolysis group). The clinical manifestations and laboratory results were analyzed. The study protocol was approved by the Ethical Review Board of Investigation in Human Beings of West China Second University Hospital, Sichuan University.Informed consent was obtained from the parents of each participating patient. There were no significant differences about birth weight, gestation age and modes of delivery among three groups(P\u003e0.05).\r\n\r\n\r\nResults\r\nThe study results were: ① Gender constituent ratio and jaundice incidence within 24 h after birth of group A compared with group B, the differences were statistically significant(χ2=9.010, 9.013; P=0.003, 0.003); but compared with group C, there were no statistically significant difference(χ2=1.670, 1.408; P=0.196, 0.235). ②The hospitalized age and the time point of visible jaundice of group A compared with group B, the differences were statistically significant(P\u003c0.001, P=0.017); but compared with group C, there were no statistically significant difference(P=0.805, 0.074). ③ Peak amplitude of serum bilirubin level and the incidence rate of acute bilirubin encephalopathy of group A compared with group B, there were no statistically significant difference(P=0.108; χ2=0.633, P=0.426); and compared with group C, there were no statistically significant difference, too(P=0.837; χ2=0.000, P=1.000).\r\n\r\n\r\nConclusions\r\nThe time point of visible jaundice of the neonatal G-6-PD deficiency overlap with the physiologic jaundices, it will delay to see the doctor and cause critical hyperbilirubinemia and acute bilirubin encephalopathy; but, when combine with ABO blood group incompatibility hemolysis, the time point of visible jaundice would ahead of schedule and get early treatment to reduce critical complication.\r\n\r\n\r\nKey words: \r\nGlucosephosphate dehydrogenase deficiency; ABO blood-group system; Hyperbilirubinemia; Infant, newborn
What problem does this paper attempt to address?